These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 101714)

  • 1. Studies on virus-inhibiting substances of bacterial origin. IV. Antiviral substances extractable from Streptococcus faecalis: its in vivo effect.
    Fujisaki M; Uchida S; Kojima M; Hotta S; Hamada C; Maeyama Y
    Kobe J Med Sci; 1978 Jun; 24(2):115-23. PubMed ID: 101714
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on virus-inhibiting substances of bacterial origin. III. Antiviral substance extractable from Streptococcus faecalis: its in vitro activities and some biological characteristics.
    Fujisaki M; Uchida S; Kojima M; Hotta S; Kuroda H; Watsuji K; Hamada K
    Kobe J Med Sci; 1978 Jun; 24(2):99-114. PubMed ID: 101717
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on virus-inhibiting substances of bacterial origin. I. Introduction.
    Hotta S
    Kobe J Med Sci; 1978 Jun; 24(2):87-90. PubMed ID: 101715
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on virus-inhibiting substances of bacterial origin. II. Inhibition of animal virus plaque formation by culture filtrates of lactic acid bacteria.
    Uchida S; Fujisaki M; Kojima M; Hotta S; Hamada K
    Kobe J Med Sci; 1978 Jun; 24(2):91-8. PubMed ID: 101716
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiviral activity of 0-beta-D-arabinofuranosyladenine. IV. Activity against intracerebral herpes simplex virus infections in mice.
    Sloan BJ; Miller FA; Ehrlich J; McLean IW; Machamer HE
    Antimicrob Agents Chemother (Bethesda); 1968; 8():161-71. PubMed ID: 4309848
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiviral activity of 9-beta-D-arabinofuranosyladenine. VI. Effect of delayed treatment on herpes simplex virus in mice.
    Miller FA; Sloan BJ; Silverman CA
    Antimicrob Agents Chemother (Bethesda); 1969; 9():192-5. PubMed ID: 5396486
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
    Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
    J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological effects of coordinated compounds of transitional metals. 7. Antiviral activity of 4-methyl-2-aminopyridine palladium chloride against herpes simplex virus type 1 and type 2 in vitro and in vivo].
    Wutzler P; Thiel KD; Tonew M; Tonew E; Schröer HP; Stelzner A
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Oct; 266(3-4):563-6. PubMed ID: 2830739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antiviral effects of pidotimod.
    Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I
    Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Virostatics in dermatology].
    Wassilew SW
    Hautarzt; 1986 May; 37(5):259-62. PubMed ID: 3733445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
    Ulbricht A; Färber I; Wutzler P
    Acta Virol; 1985 Dec; 29(6):493-8. PubMed ID: 2869661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New prodrugs of acyclic nucleosides with antiviral activity.
    Winkelmann E; Winkler I; Rolly H; Rösner M; Jähne G
    Arzneimittelforschung; 1988 Nov; 38(11):1545-8. PubMed ID: 3265058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of a carrageenan from Gigartina skottsbergii against intraperitoneal murine herpes simplex virus infection.
    Pujol CA; Scolaro LA; Ciancia M; Matulewicz MC; Cerezo AS; Damonte EB
    Planta Med; 2006 Feb; 72(2):121-5. PubMed ID: 16491446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "In vivo" and "in vitro" effects of a bacterial extract on Herpes Simplex Virus.
    Bonina L; Focà A; Merendino R; Carbone M
    Boll Soc Ital Biol Sper; 1980 Jun; 56(11):1164-8. PubMed ID: 6255968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections.
    Enright AM; Prober C
    Herpes; 2003 Aug; 10(2):32-7. PubMed ID: 14577952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of herpes simplex virus infections].
    Ishak R; Pinheiro Fde P
    Rev Paul Med; 1982; 100(2):25-9. PubMed ID: 6763755
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiviral substances: against what? For whom?].
    Hirschel B
    Ther Umsch; 1990 Aug; 47(8):653-7. PubMed ID: 2218967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon therapy for herpes simplex virus infection in a 70 years old patient].
    López García F; Enríquez Ascarza R; Rodríguez Martínez JC; Sirvent Pedreño AE
    An Med Interna; 2002 Nov; 19(11):600-1. PubMed ID: 12522901
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel selective broad-spectrum anti-DNA virus agent.
    De Clercq E; Holý A; Rosenberg I; Sakuma T; Balzarini J; Maudgal PC
    Nature; 1986 Oct 2-8; 323(6087):464-7. PubMed ID: 3762696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early foscarnet failure in herpes simplex virus infection in a patient with AIDS.
    Segal BH; Engler HD; Little R; Wilson WH; Freifeld AG; Chanock SJ
    AIDS; 1997 Mar; 11(4):552-3. PubMed ID: 9084815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.